Статья

Genomic epidemiology of SARS-CoV-2 in Russia reveals recurring cross-border transmission throughout 2020

A. Matsvay, G. Klink, K. Safina, E. Nabieva, S. Garushyants, D. Biba, G. Bazykin, I. Mikhaylov, A. Say, A. Zakamornaya, A. Khakhina, T. Lisitsa, A. Ayginin, I. Abramov, S. Bogdan, K. Kolbutova, D. Oleynikova, T. Avdeenko, G. Shipulin, S. Yudin, V. Skvortsova,
2021

SARS-CoV-2 has spread rapidly across the globe, with most nations failing to prevent or substantially delay its introduction. While many countries have imposed some limitations on trans-border passenger traffic, the effect of these measures on the spread of COVID-19 strains remains unclear. Here, we report an analysis of whole-genome sequencing of 3206 SARS-CoV-2 samples from 78 regions of Russia covering the period between March and November 2020. We describe recurring imports of multiple COVID-19 strains throughout this period, giving rise to 457 uniquely Russian transmission lineages, as well as repeated cross-border transmissions of local circulating variants out of Russia.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-09

Метаданные

Об авторах
  • A. Matsvay
    Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
  • G. Klink
    Russian Academy of Sciences
  • K. Safina
    Skolkovo Institute of Science and Technology
  • E. Nabieva
    Skolkovo Institute of Science and Technology
  • S. Garushyants
    Russian Academy of Sciences
  • D. Biba
    Skolkovo Institute of Science and Technology
  • G. Bazykin
    Skolkovo Institute of Science and Technology; Russian Academy of Sciences
  • I. Mikhaylov
    Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
  • A. Say
    Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
  • A. Zakamornaya
    Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
  • A. Khakhina
    Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
  • T. Lisitsa
    Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
  • A. Ayginin
    Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
  • I. Abramov
    Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
  • S. Bogdan
    Chief Federal State Budgetary Healthcare Institution “Centre of Hygiene and Epidemiology” of the Federal Medical Biological Agency
  • K. Kolbutova
    Chief Federal State Budgetary Healthcare Institution “Centre of Hygiene and Epidemiology” of the Federal Medical Biological Agency
  • D. Oleynikova
    Chief Federal State Budgetary Healthcare Institution “Centre of Hygiene and Epidemiology” of the Federal Medical Biological Agency
  • T. Avdeenko
    Chief Federal State Budgetary Healthcare Institution “Centre of Hygiene and Epidemiology” of the Federal Medical Biological Agency
  • G. Shipulin
    Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
  • S. Yudin
    Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
  • V. Skvortsova
    Federal Medical Biological Agency
Предметная рубрика
  • COVID-19
Тип документа
  • preprint
Источник
  • lens